These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36042568)

  • 1. Race/ethnicity differences in response to acute antihypertensive treatment of peripartum severe hypertension.
    Greene NH; Pon FF; Kilpatrick SJ
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10103-10109. PubMed ID: 36042568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
    Kantorowska A; Heiselman CJ; Halpern TA; Akerman MB; Elsayad A; Muscat JC; Sicuranza GB; Vintzileos AM; Heo HJ
    Am J Obstet Gynecol; 2020 Aug; 223(2):250.e1-250.e11. PubMed ID: 32067968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse pressure as a predictor of response to treatment for severe hypertension in pregnancy.
    Mullan SJ; Vricella LK; Edwards AM; Powel JE; Ong SK; Li X; Tomlinson TM
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100455. PubMed ID: 34375751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
    S D; Novri DA; Hamidy Y; Savira M
    F1000Res; 2022; 11():1287. PubMed ID: 37273965
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure.
    Tolcher MC; Fox KA; Sangi-Haghpeykar H; Clark SL; Belfort MA
    Am J Obstet Gynecol; 2020 Sep; 223(3):441.e1-441.e8. PubMed ID: 32544404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
    Hussein M; Mooij JM; Roujouleh H
    Kidney Blood Press Res; 2001; 24(2):124-8. PubMed ID: 11435745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of nifedipine versus hydralazine in the management of severe hypertension in pregnancy: A randomised controlled trial.
    Adebayo JA; Nwafor JI; Lawani LO; Esike CO; Olaleye AA; Adiele NA
    Niger Postgrad Med J; 2020; 27(4):317-324. PubMed ID: 33154284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
    Kilpatrick SJ; Abreo A; Greene N; Melsop K; Peterson N; Shields LE; Main EK
    Am J Obstet Gynecol; 2016 Jul; 215(1):91.e1-7. PubMed ID: 26829504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes in vascular function parameters in pregnant women with chronic hypertension and association with adverse outcome: a cohort study.
    Webster LM; Myers JE; Nelson-Piercy C; Mills C; Watt-Coote I; Khalil A; Seed PT; Cruickshank JK; Chappell LC
    Ultrasound Obstet Gynecol; 2019 May; 53(5):638-648. PubMed ID: 29380922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension.
    Sanusi AA; Leach J; Boggess K; Dugoff L; Sibai B; Lawrence K; Hughes BL; Bell J; Aagaard K; Edwards RK; Gibson KS; Haas DM; Plante L; Metz TD; Casey B; Esplin S; Longo S; Hoffman MK; Saade GR; Hoppe KK; Foroutan J; Tuuli M; Owens MY; Simhan HN; Frey H; Rosen T; Palatnik A; Baker S; August P; Reddy UM; Su EJ; Krishna I; Nguyen NA; Norton ME; Skupski D; El-Sayed YY; Ogunyemi D; Galis ZS; Harper L; Ambalavanan N; Geller NL; Kuo HC; Sinkey RG; Librizzi R; Pereira L; Magann EF; Habli M; Williams S; Mari G; Pridjian G; McKenna DS; Parrish M; Chang E; Osmundson S; Quinones J; Szychowski JM; Tita ATN
    Obstet Gynecol; 2024 Jul; 144(1):126-134. PubMed ID: 38949541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
    Wu HZ; Cheng Y; Yu D; Li JB; Jiang YF; Zhu ZN
    Hypertens Pregnancy; 2022 May; 41(2):126-138. PubMed ID: 35361052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postpartum Hypertension: Etiology, Diagnosis, and Management.
    Sharma KJ; Kilpatrick SJ
    Obstet Gynecol Surv; 2017 Apr; 72(4):248-252. PubMed ID: 28426127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labetalol Versus Nifedipine as Antihypertensive Treatment for Chronic Hypertension in Pregnancy: A Randomized Controlled Trial.
    Webster LM; Myers JE; Nelson-Piercy C; Harding K; Cruickshank JK; Watt-Coote I; Khalil A; Wiesender C; Seed PT; Chappell LC
    Hypertension; 2017 Nov; 70(5):915-922. PubMed ID: 28893900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertensive Crisis in Pregnancy.
    Wautlet CK; Hoffman MC
    Obstet Gynecol Clin North Am; 2022 Sep; 49(3):501-519. PubMed ID: 36122982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with appropriate treatment of acute-onset severe obstetrical hypertension.
    Deshmukh US; Lundsberg LS; Culhane JF; Partridge C; Reddy UM; Merriam AA; Son M
    Am J Obstet Gynecol; 2021 Sep; 225(3):329.e1-329.e10. PubMed ID: 34023314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes following intravenous magnesium compared with intravenous labetalol and oral nifedipine in 355 pregnant Han Chinese women with preeclampsia.
    Peng Z; Zhang J; Xiao Y; Dong W
    Medicine (Baltimore); 2023 Nov; 102(46):e35334. PubMed ID: 37986315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
    Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
    Gaynor MF; Wright GC; Vondracek S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
    Sridharan K; Sequeira RP
    Br J Clin Pharmacol; 2018 Sep; 84(9):1906-1916. PubMed ID: 29974489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intravenous nicardipine followed by oral labetalol in combination with nifedipine controlled-release tablet on severe peripartum hypertension.
    Lan L; Yan Y; Qi H; Qin J; Li L; Gan S; Zhang R; Zhang Y
    Ginekol Pol; 2024; 95(7):536-543. PubMed ID: 38334337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.